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Abstract Many neural disorders are characterized
by the loss of one or several types of neural cells.
Human umbilical cord-derived mesenchymal cells
(hUCMs) are capable of differentiating into neuron,
astroglia-like and oligodendrocyte cell types. How-
ever, a reliable means of inducing the selective
differentiation of hUCMs into neural cells in vitro
has not yet been established. For induction of neural
differentiation, hUCMs were seeded onto sterile glass
slides and six various cocktails using a base medium
(DMEM/LG) supplemented with 10 % FBS, retinoic
acid (RA), dimethyl sulfoxide (DMSO), epidermal
growth factor (EGF) and fibroblast growth factor
(FGF) were used to compare their effect on neuronal,
astrocyte and oligodandrocyte differentiation. The
hUCMs were positive for mesenchymal markers,
while they were negative for hematopoietic markers.
Differentiation to adipogenic and osteogenic lineage
was detected in these cells. Our data revealed that the
cocktail consisting of DMEM/LG, FBS, RA, FGF, and
EGF (DF/R/Fg/E group) induced hUCM cells to
express the highest percentage of nestin, ß-tubulin
III, neurofilament, and CNPase. The DF/Ds/Fg/E
group led to the highest percentage of GFAP expres-
sion. While the expression levels of NF, GFAP, and
CNPase were the lowest in the DF group. The least
percentage of nestin and ß-tubulin III expression was
observed in the DF/Ds group. We may conclude that
FGF and EGF are important inducers for differentia-
tion of hUCMs into neuron, astrocyte and oligoden-
drocyte. RA can induce hUCMs to differentiate into
neuron and oligodendrocyte while for astrocyte
differentiation DMSO had a pivotal role.
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Introduction
Umbilical cord is a disputed source of mesenchymal
stromal cells (MSCs). MSCs isolated from Wharton’s
Jelly (hUCMs (were shown to have surface markers,
immune properties (Fong et al. 2011; Weiss et al.
2006), and differentiation potential towards cells with
mesoderm offspring (Penolazzi et al. 2009; Schneider
et al. 2010), including adipose, bone, cartilage, skeletal
muscle, endothelium, cardiomyocyte and neuronal
cells (Ishige et al. 2009; Leeb et al. 2009; Penolazzi
et al. 2009; Wu et al. 2007), allowing replacement of
ectodermal and mesodermal tissues (Schneider et al.
2010). Several reports have characterized the in vitro
differentiation capabilities of hUCM cells (La Rocca
et al. 2009) into neuron like cells (Abdulrazzak et al.
2010; Cao and Feng 2009; Hu et al. 2009; Zhang et al.
2009b). Early studies focused on the differentiation of
MSCs into neurons and detection of astrocyte markers
received only modest attention (Boucherie and Her-
mans 2009). But recent studies showed that hUCMs
can be induced for selective differentiation into cells
with the morphologic and immunophenotypic charac-
teristics of oligodendrocyte precursor-like cells under
culture conditions (Zhang et al. 2009a).
The first proof that mouse embryonic stem cells can
be differentiated into multiple neural phenotypes in
culture was reported by Bain and colleagues in 1995 on
the base of using retinoic acid (Vawda 2008). Retinoic
acid (RA), a derivative of vitamin A, one of the most
important extrinsic neural inductive signals (Okada
et al. 2004; Paschaki et al. 2012), has been used in
combination with other elements to induce MSC
differentiation into neural cells (Scintu et al. 2006).
Various growth factors (Jori et al. 2005), such as, basic
fibroblast growth factor (bFGF) and epidermal growth
factor (EGF) are involved in transformation and mor-
phological differentiation of stem cells into neurons (Fu
et al. 2004; Rasmussen et al. 2011). Embryonic stem
cells can be induced to differentiate into neurons and
glia cells by applying a modified medium enriched with
RA or bFGF (Kim et al. 2011; Mitchell et al. 2003).
bFGF induces the cells to express a neural phenotype,
oligodendrocytes and astrocytes (Malkowski et al.
2007; Sobolewski et al. 2005). Also, dimethyl sulfoxide
(DMSO) can initiate a coordinated differentiation
program in various cell types (Adler et al. 2006).
Supplementation of DMEM-LG with b-mercap-
toethanol, DMSO, KCL and RA induced bone marrow
cells to express a neural phenotype (Mammadov et al.
2011). Also treatment with neurobasal medium, bFGF,
EGF plus B27 and RA induced Wharton‘s jelly cells to
differentiate into neuron-like cells. Markers for oligo-
dendrocytes and astrocytes were also detected in
Wharton‘s jelly cells (Zhang et al. 2009a).
In a review article on neural cell differentiation
methods Schwartz et al. (2008) showed many varia-
tions in the use of the materials to induce the
differentiation of mesenchymal cells into neural cells.
FGF and EGF have important role in the maintenance
and expansion of differentiated cells (Schwartz et al.
2008). What is important is none of the methods was
used to induce the hUCMs differentiation into neural
cells. So, we decided in this study to compare the
protocols suggested for neural induction of hUCMs
in vitro, and to provide protocols to achieve consid-
erable number of neuron, astrocyte and oligodendro-
cyte like cells from hUCM cells.
Materials and methods
Isolation of human umbilical cord matrix-derived
mesenchymal cells
All materials were purchased from Sigma Company
(Sigma-Aldrich, St. Louis, MO, USA) unless stated
otherwise. Ethical approval was obtained from the
Institutional ethical review board (approval number
69-1780) at Kerman University of Medical Sciences,
Kerman, Iran. Umbilical cords were obtained from the
patients delivering full-term infants by Caesarian sec-
tion after a written consent had been obtained (n = 5).
The cord was cut into 3–5 cm long pieces using sterile
sharp blade. Blood vessels were removed from each
piece after incising the cord lengthwise and Wharton’s
jelly was carefully separated from the amniotic mem-
brane. WJ fragments were placed in 1 mg/mL collage-
nase type B for 3 h at 37 C. Then the fragments were
washed with PBS and 0.25 mg/mL trypsin was added
for 15 min at 37 C with agitation. Then the larger
pieces were removed and the isolated cells were washed
with PBS, followed by seeding of the cells onto the
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surface of a culture dish with DMEM/LG supplemented
with 10 % (V/V) FBS penicillin (100 U/mL), strepto-
mycin (100 lg/mL), and amphotericin-B (2.5 lg/mL)
for 1 week. Within this period, the cells were fed by the
replacement with fresh medium every other day until
the cells reached an approximately 80 % confluence.
Preparation of mesenchymal stromal cells
The isolation of cells with stem cell-like morphology
(small, round cells and spindle-shaped cells) was
enhanced by selective elimination of the population of
tightly adhered cells because it seemed that differen-
tiated cells separate with retardation at the first
passage. Then this aware cell selection was followed
by incubating the remaining cells in trypsin/EDTA for
3 min so only the cells that detached in this period of
time were resuspended in growth medium and seeded
to the next flask. This method was repeated for
subsequent passages (Carlin et al. 2006).
Flow cytometry
After the fourth passage, the cells were prepared at a
concentration of 1 9 105 cells/mL in DMEM/LG with
10 % FBS. The cells were washed with PBS, fixed and
incubated for 15 min at 4 C with a 1:9 dilution of
normal goat serum in PBS to block nonspecific binding
of the antibody. The cells were labeled with the
following antibodies: FITC-conjugated anti-CD44,
FITC-conjugated anti-CD34 (Chemicon; Temecula,
CA, USA), FITC-conjugated anti-CD45 (Ediscience;
USA), PE-conjugated-anti-CD73 (BD; San Jose, CA,
USA), PE-conjugated anti-CD90 (Dako, Glostrup,
Denmark) and PE-conjugated anti-CD105 (R&D; Min-
neapolis, MN, USA) for 1 h. The cells were washed with
2 % FBS in PBS and analyzed using FACS Calibur
(BD = Becton Dickenson, USA) machine. The control
population was stained with matched isotype antibodies
(FITC-conjugated and PE-conjugated mouse IgG mono-
clonal isotype standards), which were confirmed by
positive fluorescence of limbal samples. At least 10,000
events were recorded for each sample and data were
analyzed using WinMDI software (USA).
Cell differentiation procedures
The umbilical cord MSCs at fourth passage were
induced to differentiate into osteocyte and adipocyte.
The cells were cultured in DMEM/LG medium which
consisted of either osteogenic (10 nM dexamethasone,
50 lg/mL ascorbate-phosphate, and 10 mM b-glyc-
erophosphate), or adipogenic (100 nM dexametha-
sone, 50 lg/mL ascorbate-phosphate, and 50 lg/mL
indomethacin) additives. Adipogenic differentiation
was detected by Oil Red O staining while osteogenic
differentiation was detected by Alizarin Red-S
staining.
Induction of neural differentiation
At the fourth passage, the hUCM cells were seeded at a
density of 1 9 104 cells/mL onto clean sterilized glass
slides. After 1 h incubation at 37 C, the cells were
treated with different protocols for 2 weeks. The
media were refreshed every other day. DMEM/LG and
FBS was the basic medium in all groups. Dimethyl
sulfoxide (DMSO), retinol acetate (RA), fibroblast
growth factor (FGF), and epidermal growth factor
(EGF) were used to induce hUCM cells into neural
lineages as is shown in Table 1.
Immunocytochemistry
Two weeks after the onset of treatments, the differen-
tiated cells were characterized by immunocytochem-
istry. The slides were fixed in 4 % paraformaldehyde
for 15 min followed by three times washing in PBS.
For intracellular antigens the cells were permeabilized
with PBS containing 0.2 % Triton X-100 for 10 min
and were washed two times in Tris buffered saline
(TBS). Then, the samples were incubated for 45 min
with anti-nestin (1/200, Chemicon MAB5326), anti-
neurofilament (Chemicon MAB1615), anti-b-tubulin
III (1/100, Chemicon 16230), anti-CNPase (1/200,
Chemicon MAB326) and anti-GFAP (1/400, Chemicon
MAB360) antibodies. After two washes in PBS the
antigen was localized with a peroxidase kit and DAB
chromogenic substrate solution (DAKO). The slides
were counterstained with hematoxylin (DAKO). Neg-
ative controls were considered by omitting the primary
antibody. Two hundred cells in random fields were
examined in each culture slide at 910 magnification. All
slides were studied using an optical microscope (Nikon
ys100, Nikon, Tokyo, Japan). The fraction of positive
cells was calculated by counting 10 non-overlapping
microscopic fields for each slide in at least three separate
experiments.




Data are presented as percentage of positive cells in all
groups. The level of significance was assessed by Chi




hUCM cells appeared as spherical, star like or elongated
flat fibroblast like cells with some granules on their
surfaces and cell bodies without any protrusion and
networks among the cells. By our selective protocol for
cell passage, after the second passage the morphology of
the cells appeared to have become homogenous. Our
method increased the proportion of cells with stem cell-
like morphology as well as their ability to form colonies.
The cells that remained adherent to the flask at each
passage, had large and flat morphology and they produced
few colonies as compared to the passaged cells (Fig. 1).
Flow cytometry
Human umbilical cord cells were negative for hema-
topoietic cells surface markers, CD34 and CD45.
Table 1 Distribution of various additives (as basal medium or inducer) in different groups
Additives Groups
DMEM/LG FBS (10 %) RA (10-2 M) DMSO (0.5 %) FGF (20 ng/mL) EGF (20 ng/mL)
DF H H
DF/R H H H
DF/Ds H H H
DF/R/Ds H H H H
DF/Ds/Fg/E H H H H H
DF/R/Fg/E H H H H H
Fig. 1 Morphology and long-term growth profile of hUCMs at passage four (a), Different phases of colony formation process (b, c).
Scale bars = 100 lm
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While, the mesenchymal stromal cell markers; CD44,
CD73, CD90 and CD105, were positive in these cells
(Fig. 2).
Osteogenic and adipogenic differentiation
By the end of the third week, the cells which were
induced with adipogenic medium contained numerous
oil-red positive lipid droplets (Fig. 3a). Similarly, the
MSCs became alizarin-red positive (Fig. 3c). Non-
treated control cultures did not show spontaneous
adipocyte or osteoblast transformation even after
3 weeks of cultivation (Fig. 3b, d).
Immunocytochemistry
After 2 weeks of hUCM cells culture with various
cocktails, immunocytochemistry test revealed that
induced cells express different differentiation markers
of neural lineage unequally (Fig. 4). The cocktail
consisting of DMEM/LG, FBS, RA, FGF, and EGF
(DF/R/Fg/E group) expressed the highest percentage
of nestin (69.6 %), ß-tubulin III (76 %), neurofilament
(89 %), and CNPase (16.3 %) positive cells. While, in
DF/Ds/Fg/E group the highest percentage of GFAP
expression (36 %), as an astrocyte marker, was
detected. Also, in this group and the DF/Ds/Fg/E
group, the highest cell growth was observed (data not
shown). The expression level of NF, GFAP, and
CNPase was at least in the DF group. Also the least
percentage of nestin and ß-tubulin III expression was
observed in the DF/Ds group (Table 2). Chi Square
test showed that the expression level of nestin and
CNPase in all groups was significantly higher than in
the control group (DF group). Significantly higher
expression of ß-tubulin III was detected in all groups
compared with the control, expect in the DF/R group.
While, NF and GFAP were expressed significantly
higher in all groups compared with the control, expect
in the DF/R/Ds group and the DF/Ds group, respec-
tively (Fig. 5). In addition, the evaluation of staining
intensity in the ß-tubulin III positive cells showed a
stable intensity among the groups with a detectable
staining in part of their cytoplasm (?), the whole
cytoplasm (??) and the whole cytoplasm and the cell
membrane (???) while most of the cells exhibited a
detectable staining in part of their cytoplasm in
CNPase antibody among all groups. The rest of the
antibodies showed very variant intensities among the
groups (Fig. 6).
Discussion
Understanding mesenchymal stromal cells propensity
to differentiate into various lineages is a fundamental
factor for the development of successful cell-based
therapies (Nekanti et al. 2010). In this matter, the
possible acquisition of glial functions by grafted stem
cells is now considered as a relevant explanation for
the benefit of this method in CNS disorders (Boucherie
and Hermans 2009). In addition, the investigation on
in vitro neural differentiation of stem-like cells can
lead to the understanding of some mechanisms behind
the neural tissue development (Hadinger et al. 2009).
So, in this study, the ability of several cocktails to
differentiate hUCM cells into neural cells was com-
pared. We found the cocktail consisting of DMEM/
LG, FBS, RA, FGF, and EGF (DF/R/Fg/E) induced
hUCM cells to express the highest percentage of
Fig. 2 Flow cytometry results. The red histograms are the
isotype control-stained cells, the black histograms are the
antibody-stained cells. The percentage of cells staining for each
marker is provided. hUCM cells were negative for heamato-
poietic markers; CD34 and CD45. These cells were positive for
mesenchymal stem cell markers; CD44, CD73, CD90 and
CD105. (Color figure online)
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neural and oligodendrocyte markers and the cocktail
consisting of DMEM/LG, FBS, DMSO, FGF, and
EGF (DF/Ds/Fg/E) induced the highest percentage of
astrocyte marker.
In this study, we selected the UC-derived MSCs as a
new source of stem cells (Wu et al. 2007), Studies have
shown that MSCs can easily be cultivated for more than
3 months without any senescence evidence and reduc-
tion of differentiation potential (Leeb et al. 2009). Of
course, some factors such as; basal nutrients, cell
density, growth factors and cytokines, all play signif-
icant roles in MSC differentiation (Bobis et al. 2006).
In the present investigation the effect of the defined
inductive cocktails on neural and glial differentiation
was inspected and also the roles of individual as well as
combination of components from cocktails were
examined for neural markers expression. Through the
experiments we used DMEM/LG as base medium
because our unpublished data and also Sotiropoulou
et al. (2006) have shown that low glucose concentra-
tion in DMEM-based media consistently supported
MSC growth (Sotiropoulou et al. 2006), and further-
more DMEM/LG was identified as an ideal performer
for cell differentiation (Lund et al. 2009).
In our study, the DF cocktail without any inducer
resulted in a considerable rate of expression of nestin, b-
tubulin, NF, GFAP and even CNpase (Table 2). These
data are in agreement with other studies that untreated
umbilical mesenchymal stromal cells express a number
of neural markers including nestin and b-tubulin III
(Vawda 2008) and glial proteins spontaneously (Fu
et al. 2004). Recently, some researchers had claimed
that neural differentiation of MSCs might be a reflection
of cellular stress in comparison with cells entering a true
differentiation program. But, Tio et al. (2010) have
suggested that the expression of neural markers in
MSCs is a consequence of differentiation rather than
stress. A sub-population of UCM cells exhibits neuronal
Fig. 3 Oil red positive adipocytes stained bright red (a).
Alizarin red-S positive calcium deposition appeared as a red
precipitate (c). No oil red O and alizarin red-S positive cells
were detectable in control group (b, d). Scale bars for
a = 25 lm; b, c, and d = 100 lm. (Color figure online)







Nuclei were stained in
Nestin (a) and b-tubulin III
(c) positive cells. NF (e) was
positive specially in cells
being characterized by
bipolar location, whereas
GFAP (g) and CNPase
(i) positive cells are stained
across the whole of the cells
(arrows). Mouse brain was
stained as positive control
for nestin (b), b-tubulin III
(d), GFAP (h) and CNPase
(j) and undifferentiated
hUCMs were used as
negative control (f).
Original magnification a, c,
e, g and i 9400; b, d, f, h and
j 9100
Cytotechnology (2015) 67:449–460 455
123
Author's personal copy
Table 2 Expression of specific neural and glial markers in different groups
Antibodies Groups
DF (%) DF/R (%) DF/Ds (%) DF/R/Ds (%) DF/Ds/Fg/E (%) DF/R/Fg/E (%)
Nestin 46 34.3 22 25.6 50.3 69.6
b-Tubulin III 63.3 65 56.6 73.6 73.3 76
Neurofilament 66.3 81 73.3 67.6 72.3 89
GFAP 17.3 20 32.6 35.6 36 22
CNpase 4 8.6 12 13.6 10.3 16.3
Fig. 5 Expression of specific neural and glial markers in different groups. * p B 0.05, ** p B 0.01, *** p B 0.001
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morphology and expresses certain neuronal phenotype
markers in culture, in the absence of specialized
inducing factors (Deng et al. 2006; Medicetty 2005;
Weiss et al. 2003). Maybe they are primed to differen-
tiate along a neural program.
Wislet-Gendebien et al. (2005) believed that nestin
expressed by MSCs is a necessary factor for the
emergence of neuronal differentiation of the MSCs
(Wislet-Gendebien et al. 2005). Peng et al. (2010)
found that a few number of cells was nestin positive in
adherent hUCMs (2.25 ± 0.42 %) (Peng et al. 2010).
While, the results from this study showed that nestin
expression in untreated cells (DF group) was much
higher (46 %). It seems that the long incubation time
in cell culture, in our work, has an important role in
expression of nestin. b-tubulin III is a classic marker of
immature and mature neurons that was expressed in
50–70 % of various cell types in untreated medium.
Even further treatment with neural induction medium
did not increase (73–85 %) b-tubulin III positive
hMSCs significantly (Vawda 2008). In this study,
b-tubulin III expression in untreated cells (DF group)
Fig. 6 Semi-quantification of immunostaining data for differ-
ent neural and glial markers expression in various groups.
(?) = part of cytoplasm stained, (??) = the whole cytoplasm
stained (???) = the whole cytoplasm and cell membrane
stained. (*, ** and *** show significant differences of intensity
in an antibody expression). Significant differences of intensity
are seen in all antibodies in DF/D/Fg/E group
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was nearly identical to the induced cells. FBS contains
significant levels of RA (Okada et al. 2004). We
believe that the RA level in FBS is sufficed for nestin
and b-tubulin III expression and even extra level of
RA decreased nestin expression but, did not affect b-
tubulin III expression. Of course, long-term presence
of RA (14 days) did not influence the rate of neural
positive markers (Hadinger et al. 2009). But, Fu et al.
(2004) believed that prolonged treatment with RA
(more than 12 days) forms cell to cell contacts and
constructs the appearance of a network.
Basic fibroblast growth factor and retinoic acid
differentially influence human motor neuron differ-
entiation by mechanisms which still have remained
undefined (Shin et al. 2005). The results from this
study showed that a 14 days induction of hUCM
cells with RA in combination with FGF and EGF
had the greatest influence on nestin and b-tubulin III
expression. Moreover, the presence of DMSO alone
decreased the expression of nestin and b-tubulin III,
but DMSO in combination with FGF and EGF
induced hUCMs to express considerable level of
nestin and b-tubulin. Maximum non-effective sol-
vent concentration of DMSO on induction of MSC
differentiation has been determined as high as
0.25 % as previously reported (Adler et al. 2006).
So we used a concentration of 0.5 % DMSO in our
cocktails for induction of neural differentiation.
The morphology of NF-positive differentiated
mesenchymal cells can be bipolar, multipolar or
mesenchymal (Fu et al. 2004). In the present study
although hUCM cells did not show much neurite-like
morphology, they were able to upregulate neural
markers expression. NF expression, in this study, was
different from nestin and b-tubulin III expression
among the groups. RA had an evident effect on NF
expression. Combination of RA with FGF and EGF
resulted in higher expression of NF. Contrary to us,
Portmann-Lanz et al. (2010) reported that RA had
little effects on NF expression. While, the combination
of IBMX with RA induced NF-L expression. It is
suggested that there were some synergistic interac-
tions between IBMX and RA for NF-L expression (Tio
et al. 2010).
Great controversies exist between different studies
when mesenchymal cell induction for astrocyte dif-
ferentiation is considered. Karahuseyinoglu et al.
(2007) reported that GFAP expression was negative
in both induced and noninduced hUCM cells
(Karahuseyinoglu et al. 2007). Also, Portmann-Lanz
et al. (2010) have shown that none of the method of
neural induction resulted in the generation of GFAP-
positive astrocytes. In contrast, GFAP-positive cells
were observed in less than 5 % of untreated Wharton’s
jelly cells (Fu et al. 2004). While, the expression of
these cells was slightly higher after induction with
bFGF, DMSO and BHA (Mitchell et al. 2003). Using a
three-step neural induction protocol of bFGF, b-
mercaptoethanol, neurotrophic factor-3 (NT-3), nerve
growth factor (NGF) and brain-derived neurotrophic
factor (BDNF) for 14 days, 32 % of hUCMs differ-
entiated into GFAP-positive cells (Fan et al. 2010).
The results from this study showed that the proportion
of GFAP-positive cells in untreated cells was less than
induced cells in DF/Ds/Fg/E group. GFAP can also be
expressed by immature neural progenitor cells (Sch-
windt et al. 2009). Long-term (14 days) exposure to
RA dramatically reduced the GFAP-positive cells. It
has been shown that RA can prevent the formation of
GFAP-positive astrocytes if added to the defined
phases of in vitro neural differentiation (Hadinger
et al. 2009). In this study, RA alone did not increase
the GFAP expression, but combination of RA with
DMSO increased the rate of GFAP-positive cells. We
found that DMSO alone or in combination with RA or
FGF and EGF had a positive effect on GFAP
expression in hUCM cells.
This study showed that the most appropriate cocktail
for differentiation of hUCMs to oligodendroglia was the
DF/R/Fg/E cocktail. Expression of CNPase has been
reported to be nearly identical in untreated, bFGF-
treated, and fully induced Wharton’s jelly cells (Mitch-
ell et al. 2003). In this study, untreated cells (DF group)
contained the least (4 %) CNPase positive cells com-
pared with the other treatments. Induction of hUCM
cells with RA resulted in 8.6 % CNPase expression.
When DMSO was added to RA the proportion of
CNPase positive cells increased to 13.6 %. Moreover,
addition of FGF and EGF to RA resulted in the highest
CNPase expression (16.3 %). The cellular response to
growth factors is not predefined or fixed, but to some
extent it depends on some intrinsic and extrinsic
influences (Vawda. 2008). Neural differentiation of
placental stem cells with RA plus hBDNF resulted in
5–20 % of oligodendrocytic cells (Portmann-Lanz et al.
2010). It has been reported that bFGF increased the
proliferative potential of MSCs (Schwindt et al. 2009;
Sotiropoulou et al. 2006). We suggest that the increased
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cell density with FGF and EGF can lead to cells with a
higher positive CNPase level. Portmann-Lanz et al.
(2010) also believed that higher plating densities
resulted in a greater proportion of oligodendrocytes.
Moreover, in this study like in a previous study the
induced cells had a smaller cell body with several minor
extensions. Portmann-Lanz et al. (2010) believed that
these cells were immature oligodendrocytes. In the
developing CNS, the manifestation of the microglial
phenotypes is delayed behind the formation of neurons
(Hadinger et al. 2009). Whether prolongation of the
treatment period may result in more glial cells requires
further investigations.
We may conclude that untreated human umbilical
cord mesenchymal cells appear to have an innate
neural differentiation potential. We also conclude
differentiation of human umbilical cord-derived mes-
enchymal cells into various neural phenotypes is
highly dependent on inducing agents.
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